AI assistant
Sending…
Savara Inc — Director's Dealing 2014
Jun 20, 2014
32709_dirs_2014-06-20_ec8b32aa-6525-4e5a-803e-824027ae9ec4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Mast Therapeutics, Inc. (MSTX)
CIK: 0001160308
Period of Report: 2014-06-19
Reporting Person: DITTRICH HOWARD (Director)
More from Savara Inc
Annual Report
2026
Apr 24
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Jan 27
Regulatory Filings
2026
Jan 9
Director's Dealing
2025
Dec 19
Regulatory Filings
2025
Dec 18
Director's Dealing
2025
Dec 16